Lewis Bollard

The challenge from here is how do you scale that and bring the price point down to compete with the incredibly low price point of factory farm chicken?

Yeah.

And I think how long it takes to get there and indeed whether we get there really depends on what happens from here.

We are not on a path right now when it comes to the amount of venture capital funding available, when it comes to the current startups available.

We're not on a path to reach cultivated meat that is cheaper than factory farmed chicken.

I think we could get on that path.

Sorry, ever?

Well, I mean, it depends.

Contingent on AGI and contingent on what happens with AGI, right?

Like I wouldn't rule it out, but I don't think it's the default path.

I don't think it's the most likely outcome.

Well, you would think like nanotech and bringing robotics and all these things.

But like, unless the cost of all those things goes down to close to zero, chickens are just going to be so insanely cheap.

And so, yeah, maybe.

Like, I think it is totally possible that these AGI technologies introduce incredible new proteins that help solve this problem for us.

But I don't think we should rely on it.

First, because they might not be able to solve some of these problems to the point that it is as cheap as a chicken.

But second, because you still have these cultural and political barriers.

Yeah, there's a huge difference.

So, I mean, it's probably the venture capital on the humane technology is probably less than $10 million a year.